# Tempest Therapeutics (TPST) — Earnings

TPST · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tpst/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$2.07 |
| EPS estimate | −$3.23 |
| EPS surprise | +35.91% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 11, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1544227/000095017025106558/tpst-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 11, 2025 | −$3.23 | −$2.07 | 35.91% | — | — |
| Q1 2025 | May 13, 2025 | −$3.29 | −$3.16 | 4.05% | — | — |
| Q4 2024 | Mar 27, 2025 | −$3.27 | −$4.03 | -23.08% | — | — |
| Q3 2024 | Nov 12, 2024 | −$4.71 | −$5.33 | -13.26% | — | — |
| Q2 2024 | Aug 8, 2024 | −$5.24 | −$5.46 | -4.18% | — | — |
| Q1 2024 | May 9, 2024 | −$5.23 | −$4.68 | 10.57% | — | — |
| Q4 2023 | Mar 19, 2024 | −$5.03 | −$4.94 | 1.86% | — | — |
| Q3 2023 | Nov 8, 2023 | −$7.45 | −$6.24 | 16.24% | — | — |
| Q2 2023 | Aug 10, 2023 | −$6.73 | −$7.02 | -4.35% | — | — |
| Q1 2023 | May 10, 2023 | −$8.35 | −$7.15 | 14.40% | — | — |
| Q4 2022 | Mar 22, 2023 | −$9.88 | −$7.28 | 26.35% | — | — |
| Q3 2022 | Nov 8, 2022 | −$10.43 | −$8.58 | 17.76% | — | — |
| Q2 2022 | Aug 15, 2022 | −$10.27 | −$10.27 | 0.00% | — | — |
| Q1 2022 | May 13, 2022 | −$14.52 | −$15.34 | -5.67% | — | — |
| Q4 2021 | Mar 29, 2022 | −$16.03 | −$14.56 | 9.19% | — | — |
| Q3 2021 | Nov 10, 2021 | −$13.61 | −$15.73 | -15.60% | — | — |
| Q2 2021 | Aug 12, 2021 | −$11.38 | −$99.19 | -772.00% | — | — |
| Q4 2020 | Mar 29, 2021 | −$66.30 | −$74.10 | -11.76% | — | — |
| Q3 2020 | Nov 9, 2020 | −$89.70 | −$66.30 | 26.09% | — | — |
| Q2 2020 | Aug 10, 2020 | −$106.60 | −$109.20 | -2.44% | — | — |

## Frequently Asked Questions

### When did Tempest Therapeutics (TPST) last report earnings?

Tempest Therapeutics last reported on Aug 11, 2025, covering fiscal Q2 2025.

### Did TPST beat earnings estimates?

Yes. Tempest Therapeutics reported EPS of −$2.07 for Q2 2025 against a −$3.23 estimate — a 35.91% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).